Study Assessing the Feasibility of a Surgery and Chemotherapy-Only in Children With Wnt Positive Medulloblastoma

NCT02212574 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

TERMINATED

Status

6

Enrollment

OTHER

Sponsor class

Stopped Participant relapses led to abrupt stop of study.

Conditions

Medulloblastoma

Interventions

DRUG: Lomustine
DRUG: Vincristine
DRUG: Cisplatin
DRUG: Cyclophosphamide
DRUG: Mesna
DRUG: Vincristine

Sponsor

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Collaborators

[object Object]